Clinical Trials
3 trialsNCT01290692 2023-07-03
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
TVAX Biomedical
Phase 2 Completed
NCT03650452 2021-02-18
ELEKTRA
Takeda
Phase 2 Completed
NCT00496379 2013-03-14
ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases
Dana-Farber Cancer Institute
Phase 2 Terminated